MAY 13, 2015 5:00 AM PDT

Next Generation Sequencing Panels in Clinical Diagnostics: Autism Spectrum Disorders and Eye Related Disorders

Speakers
  • John Alexander, Assistant Professor of Human Genetics, Director, Molecular Laboratory, Emory University School of Medicine, Christin Collins, Assistant Professor, Department of Human Genetics
    Biography
      Dr. Alexander is an Assistant Professor in the Department of Human Genetics and a co-director of clinical molecular diagnostics at Emory Genetics Laboratory. His clinical interests include molecular diagnostics for retinal disorders in addition to general molecular diagnostics. Dr. Alexander's research interests include evaluation of recombinant adeno-associated virus based gene therapies for retinal disorders. He received his Ph.D. in genetics from the University of Florida College of Medicine and did post-doctoral fellowships at the University of Florida and the University of Alabama at Birmingham. Dr. Alexander completed his clinical molecular genetics training at the University of Alabama at Birmingham under the direction of Dr. Bruce Korf and Dr. Ludwine Messiaen. Dr. Alexander is board certified in clinical molecular genetics and is a Fellow of the American College of Medical Genetics.

      Dr. Collins is an Assistant Professor in the Department of Human Genetics and a co-director of the molecular laboratory at Emory Genetics Laboratory. Her research interests are in investigating the genetic causes of complex diseases, specifically autism spectrum disorders (ASD). The primary focus of her clinical work is the implementation of molecular techniques to improve clinical testing for genetic disease. She received her Ph.D. from the University of Florida and did her post-doctoral fellowship in the laboratory of Dr. Louis Kunkel at the Children's Hospital Boston. Dr. Collins completed her clinical molecular genetics training at Harvard Medical School and is board certified in Clinical Molecular Genetics.

    Abstract:

    The implementation of Next Generation Sequencing (NGS) technology in the clinical laboratory has allowed for large-scale panel testing of many genes simultaneously at a reduced cost and turn-around time. Our laboratory has utilized NGS technology to develop large gene panels designed to target genes associated with specific clinical phenotypes, including autism spectrum disorders and eye-related disorders. Our results indicate that targeted panel based testing and a tiered approach is likely to result in a greater diagnostic yield for autism spectrum disorders and eye related disorders.


    Show Resources
    You May Also Like
    SEP 05, 2019 4:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 4:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    OCT 02, 2019 11:00 AM PDT
    OCT 02, 2019 11:00 AM PDT
    DATE: October 2, 2019TIME: 11:00am PDT, 2:00pm EDT Ditch the Excel spreadsheets and manage your molecular workflows entirely in your LIMS Achieve configuration of molecular workf...
    JAN 23, 2020 9:00 AM PST
    C.E. CREDITS
    JAN 23, 2020 9:00 AM PST
    DATE: January 23, 2020 TIME: 9:00am PST, 12:00pm EST...
    FEB 26, 2020 9:00 AM PST
    C.E. CREDITS
    FEB 26, 2020 9:00 AM PST
    DATE: February 26, 2020 TIME: 9:00am PST 3D cell culture and analysis and the study of organoids and spheroids are becoming more prevalent as a research method in publications as traditional...
    FEB 19, 2020 11:00 AM PST
    C.E. CREDITS
    FEB 19, 2020 11:00 AM PST
    DATE: February 19, 2020TIME: 11:00am PST, 2:00pm EST...
    NOV 07, 2019 10:00 AM PST
    C.E. CREDITS
    NOV 07, 2019 10:00 AM PST
    DATE: November 7, 2019TIME: 10:00am PST, 1:00pm EST Studying the pathogenesis of diabetes requires detailed analysis of the pancreatic islet microenvironment and its numerous c...
    Loading Comments...
    Show Resources